Develop Clinically Meaningful Antibody-Drug Conjugates
Rapidly diversifying payload, linker and antibody technologies, a surge of preclinical ADCs powering towards the clinic and a rush of ADC entering clinical trials has triggered a wave of new insight for the whole ADC field. Keep pace with the dramatic strides being made and learn from the industry’s best by joining this year’s World ADC San Diego.
Now in it’s 7th year, World ADC San Diego is the industry’s most established antibody-drug conjugate conference. Its mission: to enable drug developers to develop more clinically meaningful ADCs.
Striking the balance between ground-breaking science and research that will impact your ADC program right now, this 4 day, 4 stream conference has a comprehensive program.
This year, 86 industry experts will cover every element of ADC development from developing novel payloads with differentiated mechanisms of action and confidently interpreting ADC pharmacokinetics to design a robust clinical dosing strategy as well as effectively scaling up bioconjugation processes.
Uniting scientists from across the ADC community, join 650+ of your peers in October for the most valuable learning and networking opportunity of the year.
"World ADC is the premier ADC meeting, bringing together the thought-leaders, pioneers and next generation developments that will change how we treat diseases like cancer."
Research Corporation Technologies
“Extremely useful conference to meet other players in the modern ADC development”
“Very informative, focused conference on all aspects of ADC research and development”
|Download the 2016 Brochure|
Enhance your clinical trials knowledge of antibody drug conjugates with ADC Beacon